IP Library Granted Patent US 12,128,213
Granted Patent B2
US 12,128,213 · App. 17/161,528 · Granted Oct 29, 2024

Method of operating redundant staggered disease management systems

Inventors: Massi Joe E. Kiani (Laguna Niguel, CA); Venkatramanan Krishnamani (Irvine, CA); Hung The Vo (Fountain Valley, CA); Sai Kong Frank Lee (Irvine, CA); Kevin Hughes Pauley (Lake Forest, CA); Cristiano Dalvi (Lake Forest, CA); Jeroen Poeze (Rancho Santa Margarita, CA); Jesse Chen (Foothill Ranch, CA); Gregory A. Olsen (Lake Forest, CA); Derek Treese (Irvine, CA)
Assignee: Willow Laboratories, Inc.
A61M5/1723A61K38/28A61M2205/18A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,128,213
App. No.
17/161,528
Granted
Oct 29, 2024
Kind
B2
Abstract

A system which provides closed loop insulin administration is disclosed. The system includes redundant glucose sensors which may be interleaved in order to provide monitoring when one of the glucose sensors is in a settling period. The system may include a disease management unit which includes both a glucose sensor and an insulin pump. A closed loop disease management system which bases insulin administration on accurate glucose measurements may improve a patient's quality of life.

Claims (13)

1. A method of operating redundant disease management systems, each comprising a glucose sensor and an insulin pump, the method comprising:

during a first period comprising at least the warm-up and stabilization period for the first disease management system glucose sensor:

operating a first disease management system on a patient in a primary mode, and operating a second disease management system on the patient in a secondary mode;

during a second period comprising at least the end of life period of the first disease management system glucose sensor:

operating the first disease management system in the secondary mode, and operating the second disease management system in the primary mode; wherein the disease management system operating in the primary mode delivers insulin to the patient; and the disease management system operating in the secondary mode Provides only glucose sensor data.

2. The method of claim 1 , wherein the first disease management system insulin pump and at least one of the first or second disease management system glucose sensor are housed in a first unit.

3. The method of claim 2 , wherein the first or second disease management system glucose sensor is housed in a second unit.

4. The method of claim 3 , further comprising operating a second disease management system insulin pump based on the measurements of the first or second disease management system glucose sensor when the first disease management system is operating in the secondary mode.

5. The method of claim 4 , wherein the first unit comprises a first insulin source storing insulin and wherein the second unit comprises a second insulin source storing insulin, and wherein the first disease management system insulin pump and the second-disease management system insulin pump deliver insulin from the first insulin source or the second insulin source such that the insulin in the first insulin source and the second insulin source is emptied before the insulin in the first insulin source and the second insulin source expires.

6. The method of claim 5 , further comprising notifying the patient when it is time to replace the first unit or the second unit.

7. The method of claim 1 , wherein the first disease management system glucose sensor, the second disease management system glucose sensor, and the first disease management system insulin pump are all housed in separate units.

8. The method of claim 1 , wherein the first disease management system glucose sensor or the second disease management system glucose sensor and the first disease management system insulin pump are housed in one unit.

9. The method of claim 1 , further comprising outputting a notification to replace the first disease management system glucose sensor or the second disease management system glucose sensor with a third glucose sensor when the not replaced first disease management system glucose sensor or not replaced second disease management system glucose sensor is not operating in the warmup period, the stabilization period, or the end of life period, wherein the not replaced first disease management system glucose sensor or second disease management system glucose sensor will not be operating in the end of life period when the third glucose sensor is operating in a warmup period or a stabilization period.

Assignments (5)
PROPRIETARY INFORMATION AND INVENTOR'S AGREEMENT Recorded Apr 3, 2024
From: PAULEY, KEVIN
To: MASIMO LABORATORIES
Reel/Frame 067046/0546 →
CHANGE OF NAME Recorded Mar 21, 2024
From: CERCACOR LABORATORIES, INC.
To: WILLOW LABORATORIES, INC.
Reel/Frame 066867/0264 →
PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT Recorded Jan 29, 2024
From: TREESE, DEREK
To: CERCACOR LABORATORIES, INC.
Reel/Frame 066378/0557 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2024
From: KIANI, MASSI JOE E.; KRISHNAMANI, VENKATRAMANAN; VO, HUNG THE; LEE, SAI KONG FRANK; DALVI, CRISTIANO; POEZE, JEROEN; CHEN, JESSE; OLSEN, GREGORY A.
To: CERCACOR LABORATORIES, INC.
Reel/Frame 066378/0571 →
CHANGE OF NAME Recorded Jan 29, 2024
From: MASIMO LABORATORIES, INC.
To: CERCACOR LABORATORIES, INC.
Reel/Frame 066378/0651 →
Continuity (5)
Provisional Application 63044831 · Jun 26, 2020
Provisional Application 63015272 · Apr 24, 2020
Provisional Application 62978480 · Feb 19, 2020
Provisional Application 62968107 · Jan 30, 2020
Related Publication 20210236729A1 · Aug 5, 2021
Cited By (83)
US 1,079,020 US 1,083,653 US 1,092,244 US 1,094,735 US 1,095,288 US 1,095,483 US 1,106,466 US 1,119,639 US 1,124,917 US 1,127,209 US 1,132,251 US 1,140,023 US 12,232,905 US 12,235,947 US 12,237,081 US 12,257,183 US 12,263,018 US 12,283,374 US 12,310,695 US 12,318,175 US 12,318,176 US 12,318,196 US 12,318,229 US 12,318,580 US 12,329,548 US 12,336,796 US 12,343,108 US 12,343,142 US 12,357,181 US 12,357,203 US 12,357,237 US 12,362,596 US 12,364,403 US 12,367,973 US 12,374,843 US 12,383,194 US 12,390,114 US 12,390,140 US 12,394,285 US 12,396,667 US 12,402,816 US 12,402,843 US 12,408,869 US 12,419,588 US 12,433,524 US 12,440,128 US 12,440,171 US 12,465,270 US 12,465,286 US 12,478,272 US 12,478,293 US 12,495,967 US 12,495,968 US 12,495,998 US 12,507,952 US 12,521,021 US 12,521,039 US 12,533,068 US 12,533,089 US 12,541,293 US 12,558,033 US 12,573,286 US 12,575,797 US 12,582,313 US 12,587,806 US 12,593,980 US 12,609,013 US 12,611,117 US 12,642,491 US 12,646,617 US 12,648,718 US 12,661,039 US 12,661,488 US 12,667,307 US 12,677,331 US 12,689,232 US 12,691,223 US 12,702,202 US 12,702,333 US 12,702,755 US 12,705,325 US 12,708,328 US 12,714,369